Andrew N Schiff's Net Worth

$351 Million

Who is Andrew N Schiff?

Andrew N Schiff has an estimated net worth of $351 Million. This is based on reported shares across multiple companies, which include Zeltiq Aesthetics Inc, CEMPRA, INC., Aclaris Therapeutics, Inc., Monte Rosa Therapeutics, Inc., ViewRay, Inc., Zosano Pharma Corp, Esperion Therapeutics, Inc., ADMA BIOLOGICS, INC., Loxo Oncology, Inc., AGILE THERAPEUTICS INC, Elevation Oncology, Inc., Syros Pharmaceuticals, Inc., Cidara Therapeutics, Inc., T2 Biosystems, Inc., TRANSENTERIX INC., SUNESIS PHARMACEUTICALS INC, Durata Therapeutics, Inc., Versartis, Inc., MYOGEN INC, Sirion Holdings, Inc., Adams Respiratory Therapeutics, Inc., BARRIER THERAPEUTICS INC, INTERPHARM HOLDINGS INC, and PLANET TECHNOLOGIES, INC.

SEC CIK

Andrew N Schiff's CIK is 0001172252

Past Insider Trading and Trends

2014 was Andrew N Schiff's most active year for acquiring shares with 21 total transactions. Andrew N Schiff's most active month to acquire stocks was the month of May. 2014 was Andrew N Schiff's most active year for disposing of shares, totalling 16 transactions. Andrew N Schiff's most active month to dispose stocks was the month of October. 2011 saw Andrew N Schiff paying a total of $10,000,003.00 for 769,231 shares, this is the most they've acquired in one year. In 2018 Andrew N Schiff cashed out on 1,400,000 shares for a total of $251,202,000.00, their largest year based on trade value.